Maximum quantity allowed is 999
Please select the quantity
CAS RN: 19171-19-8 | Product Number: P2074
Pomalidomide
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Quantity |
|---|---|---|---|---|
| 25MG |
S$246.00
|
22 | ≥40 |
|
| 100MG |
S$736.50
|
≥60 | ≥40 |
|
* Please contact our distributors or
TCI
to order TCI products.
* The storage conditions are subject to change without notice.
| Product Number | P2074 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__3H__1__1N__3O__4 = 273.25 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 25MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 19171-19-8 |
| Reaxys Registry Number | 8340987 |
| PubChem Substance ID | 253660183 |
| Merck Index (14) | 135 |
| MDL Number | MFCD12756407 |
Specifications
| Appearance | White to Yellow to Green powder to crystaline |
| Purity(HPLC) | min. 98.0 area% |
Properties (reference)
| Melting Point | 313 °C(dec.) |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
| RTECS# | NR3397905 |
Transport Information:
| H.S.code* | 2925.19-000 |
Application
A Potent Anti-Myeloma, Anti-Inflammatory and Immunomodulatory Agent, Pomalicomide
Pomalidomide (CC-4047), a thalidomide analog, is an immunomodulatory agent with numerous effects on the body's immune system, and has potent anti-myeloma and anti-inflammatory activities in vitro and in vivo. Pomalidomide inhibits the cytokines tumor necrosis factor-α (TNF-α), interleukins (IL) 1β, 6, 12, and granulocyte macrophage-colony stimulating factor (GM-CSF).
References
- Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
- Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor Cells
- The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
- Pharmacological properties of thalidomide and its analogues
- Pomalidomide therapy for myeloma
- Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.